Christine Martinaitis

Title: Christine Martinaitis: Innovator in Herpes Simplex Virus Detection

Introduction

Christine Martinaitis is a notable inventor based in Columbia, MD (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of herpes simplex virus types 1 and 2. With a total of 3 patents to her name, her work has advanced the methodologies used in viral detection.

Latest Patents

One of Christine's latest patents focuses on the detection of herpes simplex virus types 1 and 2 by nucleic acid amplification. This invention relates to a method for detecting the presence or absence of herpes simplex virus (HSV) in a sample. The method amplifies a portion of the Glycoprotein G (US4) gene of HSV and detects the presence of the amplified nucleic acid using specific primers and detector primers. Furthermore, this method identifies the type of HSV, either HSV-1 or HSV-2, in a sample. The invention also includes a kit comprising the necessary primers and detector primers for use with the amplification method.

Career Highlights

Christine Martinaitis is currently employed at Becton Dickinson and Company Limited, where she continues to innovate in the field of medical diagnostics. Her work has been instrumental in developing reliable methods for detecting viral infections, which is crucial for patient care and treatment.

Collaborations

Christine has collaborated with notable colleagues, including David M Wolfe and Daretta A Yursis. These collaborations have further enhanced her research and development efforts in the medical field.

Conclusion

Christine Martinaitis is a pioneering inventor whose work in the detection of herpes simplex virus has made a significant impact in medical diagnostics. Her contributions continue to shape the future of viral detection methodologies.